Yanhua P. Tian

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Machine learning derived ORC6 as a hub biomarker for predicting tumor microenvironment, prognoses, and therapeutic responses in lung adenocarcinoma.

Machine learning derived ORC6 as a hub biomarker for predicting tumor microenvironment, prognoses, and therapeutic responses in lung adenocarcinoma.

Journal: Translational oncology

Published: January 07, 2026

Phyllodes-predominant prostatic stromal sarcoma concurrent with prostate adenocarcinoma: a case report and literature review.

Phyllodes-predominant prostatic stromal sarcoma concurrent with prostate adenocarcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: November 09, 2025

Deciphering small sequence differences in T cell receptor-antigen pairing.

Deciphering small sequence differences in T cell receptor-antigen pairing.

Journal: Nature communications

Published: November 05, 2025

SRF promotes the progression of lung adenocarcinoma by regulating lncRNA FGD5-AS1

SRF promotes the progression of lung adenocarcinoma by regulating lncRNA FGD5-AS1

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2025

Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Journal: Cancer immunology research

Published: August 25, 2025

Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure.

Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 08, 2025

Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance.

Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance.

Journal: Discover oncology

Published: January 26, 2025

Unveiling tumor-infiltrating immune cell-driven immune-mediated drug resistance in clear cell renal cell carcinoma: prognostic insights and therapeutic strategies.

Unveiling tumor-infiltrating immune cell-driven immune-mediated drug resistance in clear cell renal cell carcinoma: prognostic insights and therapeutic strategies.

Journal: Discover oncology

Published: November 30, 2024

hsa_circ_0001776 targeting miR-1265 regulates the development of lung squamous cell carcinoma and clinical significance

hsa_circ_0001776 targeting miR-1265 regulates the development of lung squamous cell carcinoma and clinical significance

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2024

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.

Journal: Cancer cell

Published: September 12, 2024

Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score.

Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score.

Journal: Discover oncology

Published: August 27, 2024

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

Journal: EBioMedicine

Published: August 06, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026